2-[1-(Biphenyl-3-yloxy)-ethyl]-4,5-dihydro-1H-imidazole

ID: ALA131775

Chembl Id: CHEMBL131775

PubChem CID: 11097489

Max Phase: Preclinical

Molecular Formula: C17H18N2O

Molecular Weight: 266.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(Oc1cccc(-c2ccccc2)c1)C1=NCCN1

Standard InChI:  InChI=1S/C17H18N2O/c1-13(17-18-10-11-19-17)20-16-9-5-8-15(12-16)14-6-3-2-4-7-14/h2-9,12-13H,10-11H2,1H3,(H,18,19)

Standard InChI Key:  XAVXPMOXUGYYNI-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

MAOA Tclin Monoamine oxidase (395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra2c Adrenergic receptor alpha-2 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.34Molecular Weight (Monoisotopic): 266.1419AlogP: 3.12#Rotatable Bonds: 4
Polar Surface Area: 33.62Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.27CX LogP: 3.10CX LogD: 1.33
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.92Np Likeness Score: -0.40

References

1. Gentili F, Bousquet P, Brasili L, Caretto M, Carrieri A, Dontenwill M, Giannella M, Marucci G, Perfumi M, Piergentili A, Quaglia W, Rascente C, Pigini M..  (2002)  Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole.,  45  (1): [PMID:11754577] [10.1021/jm0110082]
2. Dosa PI, Amin EA..  (2016)  Tactical Approaches to Interconverting GPCR Agonists and Antagonists.,  59  (3): [PMID:26390077] [10.1021/acs.jmedchem.5b00982]

Source